{"schema_version":"secwatch.filing_event.v1","accession":"0001681622-25-000013","form_type":"8-K","ticker":"VREX","cik":"0001681622","company_name":"Varex Imaging Corp","filed_at":"2025-02-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.425275+00:00","generated_at":"2026-05-27T01:41:54.815688+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Varex Q1 FY2025 revenue up 5% YoY to $200M; GAAP net loss $0.01/sh, Non-GAAP EPS $0.07","bullets":["Medical segment revenue $145M (+3% YoY); Industrial segment revenue $55M (+10% YoY).","Non-GAAP gross margin improved to 35% from 31% in prior-year quarter.","Cash flow from operations $10M; cash & securities $219M vs $213M at FY2024 year-end.","Q2 FY2025 guidance: revenue $200-215M, Non-GAAP EPS $0.05-0.20.","CEO cited solid demand and favorable sales mix driving higher-than-expected profitability."],"urls":{"canonical":"https://secwatch.observer/filing/0001681622-25-000013","json":"https://secwatch.observer/filing/0001681622-25-000013.json","markdown":"https://secwatch.observer/filing/0001681622-25-000013.md","text":"https://secwatch.observer/filing/0001681622-25-000013.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1681622/000168162225000013/0001681622-25-000013-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1681622/000168162225000013/vrex-20250206.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T01:41:54.815688+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}